Sonya Clay is named as a lobbyist on federal disclosure filings for 1 client through Novo Nordisk Inc.. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Budget/Appropriations, Medicare/Medicaid and Copyright/Patent/Trademark.
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Sonya Clay. See the Capitol Clarity rankings and method.